DK1414414T3 - Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet - Google Patents
Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladetInfo
- Publication number
- DK1414414T3 DK1414414T3 DK02754615T DK02754615T DK1414414T3 DK 1414414 T3 DK1414414 T3 DK 1414414T3 DK 02754615 T DK02754615 T DK 02754615T DK 02754615 T DK02754615 T DK 02754615T DK 1414414 T3 DK1414414 T3 DK 1414414T3
- Authority
- DK
- Denmark
- Prior art keywords
- water
- cross
- drug
- charged
- insoluble drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE20010628 | 2001-06-29 | ||
PCT/EP2002/006052 WO2003002097A1 (en) | 2001-06-29 | 2002-06-03 | Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1414414T3 true DK1414414T3 (da) | 2008-03-03 |
Family
ID=11042810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02754615T DK1414414T3 (da) | 2001-06-29 | 2002-06-03 | Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet |
Country Status (11)
Country | Link |
---|---|
US (1) | US8889182B2 (ja) |
EP (1) | EP1414414B1 (ja) |
JP (1) | JP2005503360A (ja) |
AT (1) | ATE377413T1 (ja) |
AU (1) | AU2002321061B2 (ja) |
CA (1) | CA2452575C (ja) |
DE (1) | DE60223382T2 (ja) |
DK (1) | DK1414414T3 (ja) |
ES (1) | ES2295379T3 (ja) |
NZ (1) | NZ530826A (ja) |
WO (1) | WO2003002097A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9101540B2 (en) | 2002-04-12 | 2015-08-11 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
WO2003086354A1 (en) * | 2002-04-12 | 2003-10-23 | Elan Pharma International Ltd. | Nanoparticulate megestrol formulations |
DE602004000260T2 (de) | 2003-07-22 | 2006-08-24 | Arena Pharmaceuticals, Inc., San Diego | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
WO2005109215A2 (en) * | 2004-04-30 | 2005-11-17 | Hillcrest Laboratories, Inc. | Methods and devices for removing unintentional movement in free space pointing devices |
GB0516604D0 (en) * | 2005-08-12 | 2005-09-21 | Sandoz Ag | Rapidly dispersing/disintegrating compositions |
TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物 |
WO2009023253A2 (en) | 2007-08-15 | 2009-02-19 | Arena Pharmaceuticals Inc. | IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
AU2009240586A1 (en) * | 2008-04-24 | 2009-10-29 | Evestra, Inc. | Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
ES2666324T3 (es) | 2008-10-28 | 2018-05-04 | Arena Pharmaceuticals, Inc. | Composiciones de un modulador del receptor de serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con el mismo |
ITMI20120092A1 (it) | 2012-01-26 | 2013-07-27 | Micro Macinazione S A | Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia |
JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
RU2018103338A (ru) | 2015-07-15 | 2019-08-15 | Аксовант Сайенсиз Гмбх | Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2634004B2 (de) | 1976-07-29 | 1978-08-10 | Bernhard Dr. 8000 Muenchen Lippold | Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen |
DE3320583A1 (de) | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung |
GB8403359D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
US5225192A (en) * | 1988-10-17 | 1993-07-06 | Vectorpharma International S.P.A. | Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate |
IT1227626B (it) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
IT1241417B (it) * | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
IT1246188B (it) * | 1990-07-27 | 1994-11-16 | Resa Farma | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. |
IT1298574B1 (it) * | 1998-02-06 | 2000-01-12 | Vectorpharma Int | Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione |
-
2002
- 2002-06-03 DE DE60223382T patent/DE60223382T2/de not_active Expired - Lifetime
- 2002-06-03 ES ES02754615T patent/ES2295379T3/es not_active Expired - Lifetime
- 2002-06-03 EP EP02754615A patent/EP1414414B1/en not_active Expired - Lifetime
- 2002-06-03 NZ NZ530826A patent/NZ530826A/en not_active IP Right Cessation
- 2002-06-03 US US10/481,938 patent/US8889182B2/en active Active
- 2002-06-03 WO PCT/EP2002/006052 patent/WO2003002097A1/en active IP Right Grant
- 2002-06-03 JP JP2003508336A patent/JP2005503360A/ja active Pending
- 2002-06-03 CA CA2452575A patent/CA2452575C/en not_active Expired - Fee Related
- 2002-06-03 AT AT02754615T patent/ATE377413T1/de not_active IP Right Cessation
- 2002-06-03 AU AU2002321061A patent/AU2002321061B2/en not_active Ceased
- 2002-06-03 DK DK02754615T patent/DK1414414T3/da active
Also Published As
Publication number | Publication date |
---|---|
JP2005503360A (ja) | 2005-02-03 |
CA2452575A1 (en) | 2003-01-09 |
NZ530826A (en) | 2004-09-24 |
US20040213840A1 (en) | 2004-10-28 |
EP1414414A1 (en) | 2004-05-06 |
US8889182B2 (en) | 2014-11-18 |
DE60223382D1 (de) | 2007-12-20 |
EP1414414B1 (en) | 2007-11-07 |
ATE377413T1 (de) | 2007-11-15 |
DE60223382T2 (de) | 2008-09-11 |
AU2002321061B2 (en) | 2006-08-24 |
ES2295379T3 (es) | 2008-04-16 |
WO2003002097A1 (en) | 2003-01-09 |
CA2452575C (en) | 2010-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1414414T3 (da) | Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet | |
DK1163274T3 (da) | Fremgangsmåde til tværbinding af hyaluronsyre til polymerer | |
DE60312482D1 (de) | Oligomere kettenverlängerer zur behandlung und nachbehandlung sowie dem recycling von kondensationspolymeren, darauf basierende zusammensetzungen und anwendungen derselben | |
WO2001047572A3 (en) | Device and active component for inhibiting formation of thrombus-inflammatory cell matrix | |
MX2009002653A (es) | Derivados de acido hialuronico obtenidos via reticulacion de "quimica modular". | |
ATE541587T1 (de) | Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen | |
DE69903351T2 (de) | Vernetzte hyaluronsäure und ihre medizinischen verwendungen | |
WO1995011912A3 (en) | Biopolymer synthesis utilizing surface activated, organic polymers | |
PT1017367E (pt) | Metodos para fabricar preparacoes de libertacao controlada baseadas em polimeros | |
DK0910412T3 (da) | Hydrolyserbare hydrogeler til kontrolleret frigørelse | |
ATE469179T1 (de) | Hydrogel | |
ATA7692003A (de) | Vernetztes, ultra-hochmolekulares polyethylen (uhmw-pe) | |
ATE355829T1 (de) | Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung | |
PT914095E (pt) | Metodo de fabrico de dispositivos de libertacao controlada a base de polimeros | |
CY1105515T1 (el) | Μεθοδος παρασκευης στερεων διασπορων | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
ATE520419T1 (de) | Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels | |
ATE486583T1 (de) | Pharmazeutische zusammensetzung enthaltend anastrozol | |
AR050637A1 (es) | Implantes y microesferas de liberacion prolongada de farmacos de uso oftalmico y metodos para prepararlos | |
DK1061948T3 (da) | Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf | |
WO2002004544A3 (en) | Polymers and polymerization processes | |
CN107814888B (zh) | 一种煤基聚合物水凝胶及其制备方法 | |
BR0314984A (pt) | Processo para a produção de formas de dosagem sólidas | |
AU4068201A (en) | Process for the preparation of accelerated release formulations using compressedfluids | |
BR0314838A (pt) | Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida |